CompuMed’s OsteoGram approved for marketing in China

Bone densitometry developer CompuMed has received approval to market its OsteoGram system from the State Drug Administration of the People’s Republic of China. The product is a software system that utilizes hand x-ray image-processing technology to aid in the diagnosis of osteoporosis, monitor bone density change over time, and predict fracture risk.

CompuMed is touting OsteoGram as a cost-effective testing method for osteoporosis in areas where the capital acquisition costs of dual-energy x-ray absorptiometry (DEXA) scanners are prohibitive. There are approximately 129 million post-menopausal women in China who represent model candidates for the OsteoGram test, according to the firm.

By AuntMinnie.com staff writers
June 25, 2002

Related Reading

CompuMed revenues edge higher in Q2, May 15, 2002

CompuMed hires new management team, May 13, 2002

CompuMed revenues dip, February 14, 2002

CompuMed eyes international markets, February 6, 2002

Copyright © 2002 AuntMinnie.com

Page 1 of 376
Next Page